11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - female - > 2,000 mg/kg (Fixed Dose Method)
LC50 Inhalation - Rat - male and female - 4 h - > 5.35 mg/l (OECD Test Guideline 403)
Dermal: No data available
Skin corrosion/irritation
Skin - Rabbit
Result: No skin irritation (OECD Test Guideline 404)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: No eye irritation (OECD Test Guideline 405)
Respiratory or skin sensitization
- Mouse
Result: Does not cause skin sensitization.
Germ cell mutagenicity
Test Type: Mouse
Test system: lymphocyte
Metabolic activation: with and without metabolic activation
Result: negative
Test Type: In vivo micronucleus test
Species: Mouse
Method: Mutagenicity (micronucleus test)
Result: negative
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
RTECS: OP0900000
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated., Men exposed to manganese dusts showed a decrease in fertility. Chronic manganese poisoning primarily involves the central nervous system. Early symptoms include languor, sleepiness and weakness in the legs. A stolid mask-like appearance of the face, emotional disturbances such as uncontrollable laughter and a spastic gait with tendency to fall in walking are findings in more advanced cases. High incidence of pneumonia has been found in workers exposed to the dust or fume of some manganese compounds.